One-hour plasma glucose concentration during the OGTT: What does it tell about β-cell function relative to insulin sensitivity in overweight/obese children?

Pediatric Diabetes

Volumn 12, Issue 6, 2011, Pages 572-579

  Tfayli, Hala ^a,b   Jung Lee, So ^a   Bacha, Fida ^a,b   Arslanian, Silva ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Children; Disposition index; Oral glucose tolerance test; Type 2 diabetes mellitus

Indexed keywords

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; CHILD; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; OVERWEIGHT; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 80051953000     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00745.x     Document Type: Article

References (26)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010: 87: 4-14.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004: 27: 1047-1053.
3. Dabelea D, Bell RA, D'Agostino RB, Jr et al. Incidence of diabetes in youth in the United States. Jama 2007: 297: 2716-2724.
4. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. Jama 2008: 299: 2401-2405.
5. Gregg EW. Are children the future of type 2 diabetes prevention? N Engl J Med 2010: 362: 548-550.
6. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005: 28: 638-644.
7. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002: 51(Suppl. 1): S212-S220.
8. Arslanian SA. Clamp techniques in paediatrics: what have we learned? Horm Res 2005: 64(Suppl. 3): 16-24.
9. Bacha F, Gungor N, Lee S, Arslanian SA. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 2009: 32: 100-105.
10. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes 2005: 6: 95-99.
11. Weiss R, Cali AM, Dziura J, Burgert TS, Tamborlane WV, Caprio S. Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth. Diabetes Care 2007: 30: 1845-1850.
12. Gerstein HC, Santaguida P, Raina P et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007: 78: 305-312.
13. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 2009: 32(Suppl. 2): S194-S198.
14. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008: 31: 1650-1655.
15. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009: 32: 281-286.
16. Burns SF, Lee S, Arslanian SA. In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care 2009: 32: 2087-2093.
17. Tfayli H, Lee S, Arslanian S. Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care 2010: 33: 2024-2030.
18. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002: 51: 3014-3019.
19. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983: 55: 628-634.
20. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009: 32(Suppl. 1): S62-S67.
21. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002: 19: 708-723.
22. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007: 30: 1544-1548.
23. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003: 46: 3-19.
24. Franks PW, Hanson RL, Knowler WC et al. Childhood predictors of young-onset type 2 diabetes. Diabetes 2007: 56: 2964-2972.
25. Morrison JA, Glueck CJ, Horn PS, Wang P. Childhood predictors of adult type 2 diabetes at 9- and 26-year follow-ups. Arch Pediatr Adolesc Med: 164: 53-60.
26. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 2008: 31: 2044-2049.